Lu, Wenqi
Wong, Oscar W. H. https://orcid.org/0000-0002-0499-6082
Zhu, Jie https://orcid.org/0000-0002-5789-6296
Chen, Sizhe https://orcid.org/0009-0008-0937-4873
Tun, Hein M. https://orcid.org/0000-0001-7597-5062
Wan, Yating
Xu, Zhilu https://orcid.org/0000-0002-5552-7534
Cheung, Chun Pan
Ching, Jessica Y. L. https://orcid.org/0000-0001-8257-2843
Cheong, Pui Kuan
Chan, Sandra
Wong, Samuel
Chan, Dorothy
Chan, Francis Ka Leung
Su, Qi https://orcid.org/0000-0001-9100-387X
Ng, Siew Chien https://orcid.org/0000-0002-6850-4454
Article History
Received: 5 July 2025
Accepted: 17 February 2026
First Online: 26 February 2026
Competing interests
: F.K.L.C. is a Board Member of CUHK Medical Centre. He is a co-founder, non-executive Board Chairman, honorary Chief Medical Officer, and shareholder of GenieBiome Ltd. He receives patent royalties through his affiliated institutions. He has received fees as an advisor and honoraria as a speaker for Eisai Co. Ltd., AstraZeneca, Pfizer Inc., Takeda Pharmaceutical Co., and Takeda (China) Holdings. Co. Ltd. S.C.N. has served as an advisory board member for Pfizer, Ferring, Janssen and Abbvie and received honoraria as a speaker for Ferring, Tillotts, Menarini, Janssen, Abbvie and Takeda; has received research grants through her affiliated institutions from Olympus, Ferring and Abbvie; is a founder member, non-executive director, non-executive scientific advisor and shareholder of GenieBiome Ltd which is non-remunerative; is a shareholder of MicroSigX Diagnostic Holding Limited; is a founder member, non-executive Board Director, and non-executive scientific advisor of MicroSigX Biotech Diagnostic Limited, which is non-remunerative; and receives patent royalties through her affiliated institutions. Q.S., S.C.N., and F.K.L.C. are named inventors of patent applications held by the CUHK and MagIC that cover the therapeutic and diagnostic use of the microbiome. The remaining authors declare no competing interests.